Proteonomix, Inc.
PROT · OTC
6/30/2012 | 3/31/2012 | 12/31/2011 | 9/30/2011 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | -67.3% | -0.1% | – |
| Cost of Goods Sold | $0 | $0 | -$0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | 74.5% | 648.3% | -338.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -96,820.1% | -5,606.3% | -5,402.7% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | – | -95,729% | -5,848.8% | -5,702.1% |
| EPS | 0.18 | -0.28 | -0.057 | -0.06 |
| % Growth | 164.3% | -390.4% | 4.8% | – |
| EPS Diluted | 0.18 | -0.28 | -0.057 | -0.06 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | – | -90,776.7% | -4,293.9% | -4,048.5% |